A downtown Rock Island favorite is about to make another comeback. Mental health nonprofit group Narratives QC bought the old ...

Generics Awareness Month took center stage at the Mercury Drug Q-Plaza Branch in Cainta recently, where RHEA Generics, in support of the Department of Health (DOH) and in partnership with Mercury Drug ...

Generics of Gilead Sciences' twice-yearly HIV pre-exposure prophylaxis (PrEP) Yeztugo (lenacapavir) are on the horizon, with India's Dr. Reddy’s Laboratories and Hetero Labs striking separate ...

ANDERLECHT, Belgium--(BUSINESS WIRE)--A.forall is pleased to announce the acquisition of four FDA-approved injectable generics and two late-stage pipeline assets from Provepharm's US portfolio. With ...

NEW YORK, Sept 2 (Reuters) - Some Chinese companies now racing to make generic versions of Novo Nordisk's (NOVOb.CO), opens new tab Wegovy also supplied ingredients for more than a billion makeshift ...

Chinese pharmaceutical companies are eyeing a lucrative commercial market set to materialise upon the patent expiry for Novo Nordisk’s blockbuster weight loss and type 2 diabetes (T2D) drug ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. America’s generic drug market is one of our greatest health ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Software development is one of the most rewarding careers in the world of IT. Java is one of the ...

As the global pharmaceutical landscape undergoes rapid change with advances in novel drug discovery, smarter manufacturing, and shifting trade policies, India is uniquely positioned to lead this ...

Once dismissed as unreliable, govt-supplied generic medicines are gaining traction — thanks to soaring medical costs, expanding Jan Aushadhi stores, and a slow but steady shift in public trust ...

The global branded generics market is forecasted to expand from USD 382.4 billion in 2025 to USD 860.5 billion by 2035, registering a CAGR of 8.4%. This growth is driven by rising healthcare ...